Primary Site >> Pancreatic Cancer

Gene >> DNER

  • 2014
  • 2015
  • 2016
  • 2017
  • 2018
Ref: BET bromodomain inhibitors block growth of pancreatic cancer cells in three-dimensional collagen.
PMID: 24807963
Ref: GLI2-dependent c-MYC upregulation mediates resistance of pancreatic cancer cells to the BET bromodomain inhibitor JQ1.
PMID: 25807524
Ref: Regulation of GLI Underlies a Role for BET Bromodomains in Pancreatic Cancer Growth and the Tumor Microenvironment.
PMID: 27169995
Ref: BET inhibitors block pancreatic stellate cell collagen I production and attenuate fibrosis in vivo.
PMID: 28194432
Ref: Bromodomain inhibitors, JQ1 and I-BET 762, as potential therapies for pancreatic cancer.
PMID: 28254412
Ref: Loss of KDM6A Activates Super-Enhancers to Induce Gender-Specific Squamous-like Pancreatic Cancer and Confers Sensitivity to BET Inhibitors.
PMID: 29533787
Ref: FBP1 loss contributes to BET inhibitors resistance by undermining c-Myc expression in pancreatic ductal adenocarcinoma.
PMID: 30201002